Figure 1.

FLNC mutations and their protein positions. Distributions of FLNC mutations identified in patients with hypertrophic cardiomyopathy (up) and healthy controls (down) were showed. Green color indicates benign mutations suggested by bioinformatics prediction. * indicates the mutations detected in both patients and controls